Jenny Seligmann
@JenSeligmann
Followers
1K
Following
4K
Media
98
Statuses
959
Optimist. Prof GI medical oncology. Coffee, Irn-Bru & dog enthusiast @foxtrotstudy @focus4trial @ArielTrial #pelotonuk 🇪🇺
Edinburgh born, Leeds based
Joined October 2014
Thanks for all the positive messages re FOCUS4C. Beyond delighted to see this in @guardian
1
10
43
0
0
0
🤔Pani had little effect on path response.👍Prospective trial in LACC RAS/RAF-wt EREG/AREG pts planned.❓Consider in LARC.This will be my last tweet - hope to see you on Bluesky 👋.@b.
1
0
2
🎆 Now online - my 2 fav topics in one paper.👍FOxTROT Ph2 FOLFOX+/- pani in locally advanced RAS/RAF-wt colon cancer.👍Convincing activity of anti-EGFR on long term outcomes, esp in hyperselected pts.❓Time to re-think targeted agents in LACC/LARC.
1
7
33
RT @DrAngelaLamarca: Just finished. Very interesting #MiniOral #ESMOAsia24 session in #PDAC and #Biliary that I had the pleasure to co-chai….
0
6
0
RT @AnnaliceGandini: Check out our editorial on high-risk stage II colon cancer: a call for clinicians to exercise caution when withdrawing….
0
2
0
Epic @chrisjmwilliams leading this 👍🏻.Very timely review post #ESMO24 neoadjuvant colon IO data!.Delighted to be involved plus international 🤝.@NatRevClinOncol @OncoAlert @LIMRLeeds.
0
3
10
Neoadjuvant immunotherapy for msi-h colon and rectal cancer 👍🏻.But emerging data on complications not seen with chemo.Project initiated after a pt developed bowel obstruction due to stricturing response to IO.➡️emergency resection.➡️pCR.👏@Jplatt_19 & our international 🤝.
Delighted to have this published. Fantastic effort from all involved!. ✅ ICIs transforming Tx of dMMR CRC.✅ Common toxicities now well recognised but. 💥 Is bowel obstruction a rare complication when primary tumour in situ?!. International case series in @ESMO_Open ⬇️⬇️⬇️
1
11
38
Tumour immune markers absolutely relevant in risk stratification for early stage colon cancer ✅.Great collaboration with @RocheDiaUSA @UniversityLeeds .👏👏@chrisjmwilliams published in.@JCO_ASCO 🤩.
0
1
11
Plus a mystery LBA in this session…🤩 💥💥💥.Can’t wait #ESMO24.
Abstract titles for #ESMO24 now online! Full NICHE-3 cohort (59 pts with dMMR colon cancer treated with neoadj nivo/rela) will be presented in proferred paper session + more neoadj IO from Imhotep, and wonderful @JenSeligmann as discussant. Stay tuned for more exciting💥💥💥news!
1
3
13
RT @p_ciracimd: How to integrate NACT in locally advanced colon cancer: .👉 enroll pts in clinical trials.👉 gain experience .👉 MDT is crucia….
0
7
0
🙏🏽🙏🏽@ChiaraCrem1 .That’s a wrap for day 1 of #ESMOGI24.Privilege to share the stage with @JeanneTie to discuss advances in localised colon cancer.@FoxtrotStudy @DucreuxMichel.
Outstanding presentation by @JenSeligmann at #ESMOGI24 about neoadj strategies to modify the status quo in localized colon cancer. Academic research will be the key, sure! 💪🏻 @myESMO #ESMOAmbassadors
1
5
35
RT @FoxtrotStudy: Halfway there! I'm pleased to announce 10 out of our 20 selected sites have now opened to FOxTROT 4!.Great job to everyon….
0
3
0
RT @FoxtrotStudy: Congratulations to Dr Niki Christou and the team in France who have randomised their first FOxTROT 2 participant! 🎉🎉🎉. I'….
0
4
0
RT @FoxtrotStudy: Congratulations to the FOxTROT & ARIEL radiology support team for collecting 2 prestigious awards as top 20 presenters at….
0
4
0
RT @giconnectInfo: 🚨 #LowerGIcancer highlights from #ASCO24 🚨. Prof. @JenSeligmann & Dr @ModestDominik share their views on new data from #….
0
8
0
RT @BJSurgery: Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.➡️ ht….
0
53
0
And we’re off!!! Testing neoadjuvant EC in BRAF-mut locally advanced colon cancer. 🙏🏽 @DrSonaliDG and team @VelindreTrust.
Congratulations to the team at Velindre Cancer Centre for randomising our first FOxTROT 4 participant! 🎉🎉🎉.@VelindreTrust @JenSeligmann @Janetgr83596731 @DrSonaliDG @LeedsCTRU.
2
4
23
Here we are investigating neoadjuvant encorafinib + cetuximab in locally advanced BRAF-mutated colon cancer c/w chemotherapy. Important to find new strategies for this poor prognosis population 👍💪🏻@Janetgr83596731.
0
8
37